Assenagon Asset Management S.A. Chemo Centryx, Inc. Transaction History

Assenagon Asset Management S.A.

$47.8 Billion
Q3 2024

Shares

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Oct 27, 2022	BUY	$22.17 - $51.8 $8.95 Million - $20.9 Million	403,598 Added 289.9%	542,817 $28 Million
Q2 2022 Jul 27, 2022	SELL	$15.36 - $27.51 $346,460 - $620,515	-22,556 Reduced 13.94%	139,219 $3.45 Million
Q1 2022 Apr 25, 2022	SELL	$22.22 - $39.12 $1.55 Million - $2.73 Million	-69,687 Reduced 30.11%	161,775 $4.06 Million
Q4 2021 Feb 01, 2022	BUY	$18.38 - $40.5 $4.25 Million - $9.37 Million	231,462 New	231,462 $8.43 Million
Q3 2021 Oct 19, 2021	SELL	$13.18 - $19.83 $1.37 Million - $2.07 Million	-104,213 Closed	0 $0
Q2 2021 Jul 15, 2021	BUY	$9.59 - $50.88 $999,402 - $5.3 Million	104,213 New	104,213 $1.4 Million
Q1 2021 Apr 26, 2021	SELL	$49.53 - $68.4 $2.44 Million - $3.37 Million	-49,294 Closed	0 $0
Q4 2020 Feb 01, 2021	BUY	$47.25 - $65.16 $1.85 Million - $2.55 Million	39,186 Added 387.67%	49,294 $3.05 Million
Q3 2020 Oct 07, 2020	BUY	$46.35 - $61.69 $468,505 - $623,562	10,108 New	10,108 $554,000
Q4 2019 Jan 17, 2020	SELL	$6.81 - $39.55 $846,673 - $4.92 Million	-124,328 Closed	0 $0
Q3 2019 Oct 16, 2019	BUY	$6.47 - $8.96 $804,402 - $1.11 Million	124,328 New	124,328 $843,000

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.